Ready to play
Ready to play
GLP-1-based medications, originally developed for diabetes and obesity, are gaining attention for their potential broader health benefits. Beyond weight loss, they may improve sleep quality, reduce inflammation, and support organ function, with ongoing studies exploring their effects on liver disease, kidney health, addiction, and inflammation-related conditions. Experts caution that while some benefits are supported by evidence, others remain unproven, and side effects and costs should be carefully considered.
Notice: This Is an AI-Generated Summary
Comments (0)